Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson’s Disease and identifies clear opportunities to improve treatment options
ALTRINCHAM, England, July 3, 2025 /PRNewswire/ — A new study is the first to examine the application of behavioural science in getting underused therapies for Parkinson’s…
